FKBP5 and metabolic disease: Aberrant DNA methylation at FKBP5 cytosine–phosphate–guanine (CpG) sites, such as cg22363520 and cg00862770, has been implicated in mental health disorders and metabolic diseases, including Type 2 diabetes.